Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Calcium SCHEMBL29819442 | 0.84 | CA2 (0.53) | CA2CA1EPHX1PTPN11CA7 | |
| SCHEMBL11954912 | 0.83 | CA2 (0.36) | CA2CA1EPHX1CA7CA13 | |
| SCHEMBL29011790 | 0.82 | CA2 (0.46) | CA2CA1EPHX1PTPN11CA7 | |
| SCHEMBL27445063 | 0.82 | CA2 (0.33) | CA2CA1 | |
| SCHEMBL25899608 | 0.81 | EPHX1 (0.38) | CA2CA1EPHX1 | |
| SCHEMBL37874 | 0.81 | CA2 (0.56) | CA2CA1EPHX1PTPN11CA7 | |
| SCHEMBL4457449 | 0.81 | CA2 (0.56) | CA2CA1EPHX1PTPN11CA7 | |
| SCHEMBL14713537 | 0.80 | CA2 (0.32) | CA2CA1 | |
| SCHEMBL31096883 | 0.79 | CA2 (0.48) | CA2CA1EPHX1PTPN11CA7 | |
| SCHEMBL23709132 | 0.78 | CA2 (0.31) | CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116143669-A | Amphiphilic organic zinc salt and preparation method and application thereof | 华中科技大学 | 2023-05-23 | — | — | CN | claimed |
| CN-116143669-B | Amphiphilic organic zinc salt and preparation method and application thereof | 华中科技大学 | 2025-05-09 | — | — | CN | disclosed |
| US-20250121073-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-04-17 | — | — | US | disclosed |
| CN-119774890-A | All-inorganic perovskite CsPbIBr2Film, preparation method and battery | 郑州大学 | 2025-04-08 | — | — | CN | disclosed |
| US-12150995-B2 | IRAK degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2024-11-26 | — | — | US | disclosed |
| WO-2024146502-A1 | WEE1 DEGRADING COMPOUNDS | BEIJING NEOX BIOTECH LIMITED (CN) | 2024-07-11 | — | — | WO | disclosed |
| US-20240215890-A1 | Bio-Electrode, Bio-Electrode Composition, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240213534-A1 | NOVEL ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| WO-2024061768-A1 | AZOLE PESTICIDAL COMPOUNDS | BASF SE (DE) | 2024-03-28 | — | — | WO | disclosed |
| US-11912825-B2 | Polymers derived from 2,2′-bisimidazoles | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2024-02-27 | — | — | US | disclosed |
| US-20090103162-A1 | Durable electrooptic devices comprising ionic liquids | TRIAD NATIONAL SECURITY, LLC | 2009-04-23 | — | — | US | disclosed |
| US-7450292-B1 | for electrochromic devices such as rear view mirrors and displays with low leakage currents are prepared using inexpensive, low conductivity conductors; electrolytes include bifunctional redox dyes and molten salt solvents with enhanced stability toward ultraviolet radiation | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-11-11 | — | — | US | disclosed |
| US-20080266642-A1 | DURABLE ELECTROOPTIC DEVICES COMPRISING IONIC LIQUIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-10-30 | — | — | US | disclosed |
| US-20080220371-A1 | PHOTOSENSITIVE COMPOSITION, COMPOUND USED FOR PHOTOSENSITIVE COMPOSITION AND PATTERN-FORMING METHOD USING PHOTOSENSITIVE COMPOSITION | FUJIFILM CORPORATION (JP) | 2008-09-11 | — | — | US | disclosed |
| WO-2007147222-A9 | NOVEL IONIC LIQUIDS | UNIV LEUVEN KATH (BE) | 2008-02-14 | — | — | WO | disclosed |
| US-7285616-B2 | Aromatic polymer, method for producing the same and uses thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-23 | — | — | US | disclosed |
| US-7285616-B2 | Aromatic polymer, method for producing the same and uses thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-23 | — | — | US | disclosed |
| US-20070235696-A1 | Preparation and purification of ionic liquids and precursors | LOS ALAMOS NATIONAL SECURITY, LLC | 2007-10-11 | — | — | US | disclosed |
| EP-1738897-A1 | OPTICAL FUNCTIONAL LAMINATE | Daikin Industries, Ltd. (JP) | 2007-01-03 | — | — | EP | disclosed |
| WO-2004024718-A1 | IMIDAZOLIDINEDIONE-DERIVATIVES AND THEIR USE AS METALLOPROTEINASE INHIBITORS | ASTRAZENECA AB (SE) | 2004-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080220371-A1 | PHOTOSENSITIVE COMPOSITION, COMPOUND USED FOR PHOTOSENSITIVE COMPOSITION AND PATTERN-FORMING METHOD USING PHOTOSENSITIVE COMPOSITION | RARA, RARB, RARG | CA2 1865/4885CA1 755/4885EPHX1 675/4885 |
| US-20240213534-A1 | NOVEL ADDITIVE FOR NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING SAME | SLC8A1, CACNA1S, CACNA1F | CA2 97/4885CA1 41/4885EPHX1 1753/4885 |
| US-11912825-B2 | Polymers derived from 2,2′-bisimidazoles | PARG, PARN, NOP2 | CA2 2700/4885CA1 3951/4885EPHX1 4724/4885 |
| US-20250121073-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | CA2 4617/4885CA1 4622/4885EPHX1 1684/4885 |
| US-12150995-B2 | IRAK degraders and uses thereof | IRAK2, IRAK3, IRAK1 | CA2 4617/4885CA1 4622/4885EPHX1 1684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.